Patents by Inventor Devrim Gozuacik

Devrim Gozuacik has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11473856
    Abstract: A heat exchanger having a heat transfer surface provided with hyperthermophilic bacteria. The hyperthermophilic bacteria can be from the genera Archaea. The hyperthermophilic bacteria can further be from the genus Sulfolobus, and the hyperthermophilic bacteria can further be from the species Sulfolobus solfataricus. The heat exchanger can be adapted to pool-boiling heat transfer.
    Type: Grant
    Filed: April 2, 2018
    Date of Patent: October 18, 2022
    Assignee: SABANCI UNIVERSITESI
    Inventors: Ali Kosar, Devrim Gozuacik, Abdolali Khalili Sadaghiani, Yunus Akkoc, Ahmad Reza Motezakker
  • Publication number: 20210087451
    Abstract: A heat exchanger having a heat transfer surface provided with hyperthermophilic bacteria. The hyperthermophilic bacteria can be from the genera Archaea. The hyperthermophilic bacteria can further be from the genus Sulfolobus, and the hyperthermophilic bacteria can further be from the species Sulfolobus solfataricus. The heat exchanger can be adapted to pool-boiling heat transfer.
    Type: Application
    Filed: April 2, 2018
    Publication date: March 25, 2021
    Applicant: SABANCI UNIVERSITESI
    Inventors: Ali KOSAR, Devrim GOZUACIK, Abdolali KHALILI SADAGHIANI, Yunus AKKOC, Ahmad Reza MOTEZAKKER
  • Publication number: 20210023239
    Abstract: The present invention relates to oligonucleotide carriers for oligonucleotide delivery to a subject to provide gene therapy. More particularly, the present invention relates to therapeutic nanoparticles for microRNA (miRNA) delivery to a subject. More particularly, the present invention relates to therapeutic nanoparticles wherein miRNA is bindable to biocompatible nanoparticles using natural gene carrier Argonaute (AGO) protein or a variant thereof. Optionally, therapeutic nanoparticles of the present invention additionally contain targeting moieties for targeting therapeutic nanoparticles to cancer cells and/or chemotherapeutic agents. Optionally, biocompatible nanoparticles are trackable nanoparticles, such as superparamagnetic iron oxide nanoparticles (SPION), to provide multifunctional theranostics.
    Type: Application
    Filed: March 10, 2018
    Publication date: January 28, 2021
    Applicants: KOC UNIVERSITESI, SABANCI UNIVERSITESI, SABANCI UNIVERSITESI NANOTEKNOLOJI ARASTIRMA VE UYGULAMA MERKEZI
    Inventors: Havva Yagci ACAR, Devrim GOZUACIK, Ali KOSAR, Ozlem UNAL, Muhammed KOCAK, Yunus AKKOC, Merve ZUVIN
  • Patent number: 10385306
    Abstract: A device for single-cell analysis according to an embodiment of the present invention comprises: a substrate; a gap between the substrate and porous membrane which is a space for culture medium; and a porous membrane formed on having a pore capable of isolating a second cell into single cell units. A method for single-cell analysis according to an embodiment of the present invention comprises: Culturing a first cell in a culture medium on a bottom side of porous membrane; Applying a sample including a second cell on a porous membrane in a culture medium; Isolating the second cell into single cell units in a pore existing in the porous membrane with a external force such as agitation and gravitational force; Generating an interaction situation between the first cells and the single cell-level second cell; Analyzing a cellular phenomena of the first cell or the second cell.
    Type: Grant
    Filed: December 18, 2015
    Date of Patent: August 20, 2019
    Assignee: UNIST(ULSAN NATIONAL INSTITUTE OF SCIENCE AND TECHNOLOGY)
    Inventors: Yoon Kyoung Cho, Cedric Bathany, Jun Young Kim, Devrim Gozuacik
  • Publication number: 20180002654
    Abstract: A device for single-cell analysis according to an embodiment of the present invention comprises: a substrate; a gap between the substrate and porous membrane which is a space for culture medium; and a porous membrane formed on having a pore capable of isolating a second cell into single cell units. A method for single-cell analysis according to an embodiment of the present invention comprises: Culturing a first cell in a culture medium on a bottom side of porous membrane; Applying a sample including a second cell on a porous membrane in a culture medium; Isolating the second cell into single cell units in a pore existing in the porous membrane with a external force such as agitation and gravitational force; Generating an interaction situation between the first cells and the single cell-level second cell; Analyzing a cellular phenomena of the first cell or the second cell.
    Type: Application
    Filed: December 18, 2015
    Publication date: January 4, 2018
    Inventors: Yoon Kyoung CHO, Cedric BATHANY, Jun Young KIM, Devrim GOZUACIK
  • Publication number: 20130302404
    Abstract: The invention is use of at least one miRNA (micro Ribonucleic Acid) being member of the hsa-miR-376 family or at least one inhibitor of said miRNA for the diagnosis, prophylaxis, treatment and follow-up during and after treatment of at least one disease involving autophagy abnormalities by acting on autophagy-related genes and proteins; and method thereof.
    Type: Application
    Filed: September 27, 2010
    Publication date: November 14, 2013
    Inventors: Devrim Gozuacik, Gozde Korkmaz